Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

US Patent 12233093 · Granted Feb 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD47 targeted therapies for the treatment of infectious disease2025
CD47 targeted therapies for the treatment of infectious disease2025
Interleukin-18 variants and methods of use2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Interleukin-18 variants and methods of use2025
Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Superagonists, partial agonists and antagonists of interleukin-22025